A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis

By Teml Alexander   Schwab Matthias   Harrer Marieluise   Miehsler Wolfgang   Schaeffeler Elke   Dejaco Clemens   Mantl Martina   Schneider Barbara   Vogelsang Harald   Reinisch Walter  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 10, 2005-10 ,pp. : 1205-1213

Informa Healthcare

Access to resources Recommend Favorite

Open-Label Phase I Clinical Study to Assess the Safety and Efficacy of Cilostazol in Patients Undergoing Internal Carotid Artery Stent Placement

By  

Interventional Neurology, Vol. 6, Iss. 1-2, 2016-12 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)

By Jung Norma   Hellmann Matthias   Hoheisel Reimund   Lehmann Clara   Haase Ingo   Perniok Andreas   Hallek Michael   Rubbert Andrea  

Clinical Rheumatology, Vol. 29, Iss. 10, 2010-10 ,pp. : 1169-1173

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 6, 2007-04 ,pp. : 401-405

Karger

Access to resources Recommend Favorite

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

By Okita Kiwamu   Sakaida Isao   Okada Mitsuru   Kaneko Akira   Chayama Kazuaki   Kato Michio   Sata Michio   Yoshihara Naomasa   Ono Noriyuki   Murawaki Yoshikazu  

Journal of Gastroenterology, Vol. 45, Iss. 9, 2010-09 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite